TradingMarkets’ 11 Stocks You Need To Know About Today
Best Buy
(
BBY |
Quote |
Chart |
News |
PowerRating) reported Q4 of $1.55, in-line $9.227 billion, also
in line. The report was delayed.
Taser
(
TASR |
Quote |
Chart |
News |
PowerRating) forecast weaker-than-expected sales; shares are
trading down pre-open. The company now expects sales of $10 million in Q1 vs.
$13.6 million previously forecast. The company blames significant adverse
publicity.”
Biogen
(
BIIB |
Quote |
Chart |
News |
PowerRating) told investors not to rely on recent guidance issue
on February 7, before the company suspended sales of Tysabri.
Palmsource
(
PRSC |
Quote |
Chart |
News |
PowerRating) reported a loss for Q3 on lighter sales but
forecast a smaller loss than previously expected.
Medicis
(
MRX |
Quote |
Chart |
News |
PowerRating) and Allergan
(
AGN |
Quote |
Chart |
News |
PowerRating) were the subject of a
positive article in Barron’s Online.
Cognos
(
COGN |
Quote |
Chart |
News |
PowerRating) beat estimates but guided lower for Q1.Separately,
the company sign a multi-year agreement with Amazon.com. UBS upgraded the stock
to ‘buy’ from ‘neutral.’
Carl Icahn plans to increase his stake in Hollywood Entertainment
(
HLYW |
Quote |
Chart |
News |
PowerRating) to 10.84%.
Seprecor
(
SEPR |
Quote |
Chart |
News |
PowerRating) expects to begin selling its sleeping pill
Lunesta in a few days.
Red Hat’s
(
RHAT |
Quote |
Chart |
News |
PowerRating) sales more than doubled and increased its stock
buyback program.
Alopharma
(
ALOP |
Quote |
Chart |
News |
PowerRating) missed by 0.04 and guided lower.